sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

Multiple Sclerosis Therapeutics Market Scope And Analysis

  • Report Code : TIPRE00004057
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 169
Buy Now

Multiple Sclerosis Therapeutics Market Scope by 2031

Buy Now

Multiple Sclerosis Therapeutics Market Report Multiple Sclerosis Therapeutics Market Size and Share Multiple Sclerosis Therapeutics Market Scope and Analysis

Multiple Sclerosis Therapeutics Market Report Scope

Report Attribute Details
Market size in 2019 US$ 24.03 Billion
Market Size by 2027 US$ 39.22 Billion
Global CAGR (2019 - 2027) 6.5%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By Drug Class
  • Immunosuppressant and Immunomodulators
By Route of Administration
  • Injectable and Oral
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • E-Commerce
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Merck Co Inc
  • Novartis AG
  • Bayer AG
  • Sanofi
  • Bristol Myers Squibb Company
  • Horizon Therapeutics plc
  • TEVA PHARMACEUTICAL INDUSTRIES LTD
  • Takeda Pharmaceutical Company Limited
  • F HOFFMANN LA ROCHE LTD